Peroxidase activity in mammary tumors-Effect of tamoxifen

Joseph Levy, Yair Liel, Bianca Feldman, Lilian Aflallo, Seymour M. Glick

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Dimethylbenz(a)anthracen (DMBA)-induced tumors in rats were studied for changes in size, cytosolic estrogen (ER) and progesterone (PgR) receptors, and for peroxidase activity before treatment, after 15 days of treatment with the anti-estrogen tamoxifen, and 15 days following cessation of the treatment. Mean size of the tumors decreased significantly during the treatment period to 1/3 the original size and ER and PgR decreased significantly to 1/5 their original levels. Peroxidase activity increased 30-fold. All the changes reversed significantly 15 days after cessation of tamoxifen treatment. These results are consistent with a previous study in which regression of the tumors was induced by castration and recovery was brought about by treatment with estradiol. In DMBA-induced mammary tumors in rats, peroxidase activity in regressing and growing tumors is in inverse relation to changes in tumor size, ER and PgR, which are accepted indicators of estrogenic activity.

Original languageEnglish
Pages (from-to)1023-1026
Number of pages4
JournalEuropean Journal of Cancer and Clinical Oncology
Issue number9
StatePublished - 1 Jan 1981
Externally publishedYes

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Peroxidase activity in mammary tumors-Effect of tamoxifen'. Together they form a unique fingerprint.

Cite this